Published in Hepatitis Weekly, June 17th, 2002
Explaining that HBV capsids can be produced in the lab, Adam Zlotnick and colleagues at the University of Oklahoma Health Sciences Center recently described in the Journal of Virology how bis-ANS acts as a wedge to disrupt capsid assembly. After binding to capsid building blocks, the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.